Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ACTRN12626000696392) titled 'Corneal immune cell dynamics in low-level light therapy' on June 11.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Primary Sponsor: The University of Melbourne
Condition:
Dry eye disease
Meibomian gland dysfunction
Dry eye disease
Meibomian gland dysfunction
Eye - Diseases / disorders of the eye
Intervention:
The study interventions comprise low-level light therapy delivered via a clinical device (Eye-light, Espansione Group, Italy) used for treating dry eye. This device is TGA-approved (ARTG list...